Press Release Distribution and Management

Orphazyme initiates directed issue and private placement of shares

February 06, 2020 11:02 ET | Source: ORPHAZYME A/S

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN OFFER OF...

Preliminary results for 2019 and financial outlook for 2020

February 04, 2020 01:03 ET | Source: ORPHAZYME A/S

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES AND THE SECURITIES REFERRED TO HEREIN MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION...

Capital increase of 20,650 shares (equivalent to approximately 0.10% of the existing shares) in Orphazyme A/S as a result of an issue of bonus shares to KLSDC and UCLB

January 31, 2020 02:26 ET | Source: ORPHAZYME A/S

Orphazyme A/SCompany announcement No. 06/2020 ...

Resolutions passed at the Extraordinary General Meeting in Orphazyme A/S

January 25, 2020 09:05 ET | Source: ORPHAZYME A/S

Orphazyme A/SCompany announcement No. 05/2020Company Registration No. 32266355 Copenhagen, Denmark, January 25,...

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

January 07, 2020 09:16 ET | Source: ORPHAZYME A/S

Orphazyme A/SCompany announcement No. 04/2020 ...

Orphazyme announces US Early Access Program for Niemann-Pick disease Type C

January 06, 2020 08:00 ET | Source: ORPHAZYME A/S

Orphazyme A/SCompany announcement No....